Elite Pharmaceuticals Inc (ELTP)

[WeeZuhl]

ELI-200 Revealed!

Based on my analysis of the Phase 3 efficacy trial published today on clinicaltrials.gov, my opinion is that ELI-200 has been revealed as:

1. Oxycodone
2. Intermediate dose = 15mg
3. Intermediate time-release = 6-8 hours

I believe ELI-200 is a novel, intermediate-release abuse-deterrent oxycodone formulation. As such, ELI-200 can be used “as needed” for acute pain and breakthrough pain, like OxyIR; and ELI-200 can be used “scheduled” for chronic pain, like OxyContin. Look at the chart below. Immediate-release opioids dwarf extended-release opioids in total prescriptions, and ELI-200 captures both.

Example Rx’s:

1. OxyNal 15mg 1 tab PO Q6H prn moderate-severe pain
Dispense: #20 for 10 days

2. OxyNal 15mg 1 tab PO Q8H sched
Disp: #90 for 30 days

3. OxyNal 15mg 1 tab PO Q8H sched and 1 tab PO Q8H prn breakthrough pain
Disp: #150 for 30 days